Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__86_B4,12 | Lung | Primary cancer | 3,991 | Tumor/Malignant | 32.8% | 0.52 | 0.91 |
| NSCLC_38242124__IMC__86_B4,13 | Lung | Primary cancer | 2,843 | Tumor/Malignant | 88.1% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__86_B4,14 | Lung | Primary cancer | 2,510 | Tumor/Malignant | 65.9% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__86_B4,2 | Lung | Primary cancer | 2,771 | Tumor/Malignant | 24.1% | 0.90 | 0.30 |
| NSCLC_38242124__IMC__86_B4,3 | Lung | Primary cancer | 1,020 | Stromal | 31.0% | 0.49 | 0.85 |
| NSCLC_38242124__IMC__86_B4,5 | Lung | Primary cancer | 291 | Tumor/Malignant | 67.7% | 0.34 | 0.96 |
| NSCLC_38242124__IMC__86_B4,6 | Lung | Primary cancer | 310 | Stromal | 63.9% | 0.42 | 0.78 |
| NSCLC_38242124__IMC__86_B4,7 | Lung | Primary cancer | 1,610 | Tumor/Malignant | 73.4% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__86_B4,8 | Lung | Primary cancer | 303 | Tumor/Malignant | 54.8% | 0.45 | 0.78 |
| NSCLC_38242124__IMC__86_B4,9 | Lung | Primary cancer | 685 | Stromal | 35.0% | 0.38 | 0.87 |
| NSCLC_38242124__IMC__86_B5,1 | Lung | Primary cancer | 3,182 | Tumor/Malignant | 67.1% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__86_B5,10 | Lung | Primary cancer | 2,357 | Tumor/Malignant | 53.4% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__86_B5,12 | Lung | Primary cancer | 137 | Tumor/Malignant | 52.6% | 0.47 | 0.89 |
| NSCLC_38242124__IMC__86_B5,13 | Lung | Primary cancer | 3,387 | Tumor/Malignant | 87.7% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__86_B5,14 | Lung | Primary cancer | 2,142 | Tumor/Malignant | 30.1% | 0.91 | 0.28 |
| NSCLC_38242124__IMC__86_B5,2 | Lung | Primary cancer | 2,666 | Immune | 45.8% | 0.90 | 0.31 |
| NSCLC_38242124__IMC__86_B5,3 | Lung | Primary cancer | 3,885 | Immune | 29.1% | 0.90 | 0.29 |
| NSCLC_38242124__IMC__86_B5,4 | Lung | Primary cancer | 2,337 | Tumor/Malignant | 38.2% | 0.85 | 0.43 |
| NSCLC_38242124__IMC__86_B5,5 | Lung | Primary cancer | 2,876 | Tumor/Malignant | 50.6% | 0.95 | 0.13 |
| NSCLC_38242124__IMC__86_B5,6 | Lung | Primary cancer | 3,764 | Stromal | 68.7% | 0.96 | 0.11 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__86_B4,12 | Lung | Primary cancer | 3,991 | Tumor/Malignant | 29.7% | 0.54 | 0.97 |
| NSCLC_38242124__IMC__86_B4,13 | Lung | Primary cancer | 2,843 | Tumor/Malignant | 88.3% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__86_B4,14 | Lung | Primary cancer | 2,510 | Tumor/Malignant | 56.8% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__86_B4,2 | Lung | Primary cancer | 2,771 | Tumor/Malignant | 24.6% | 0.90 | 0.31 |
| NSCLC_38242124__IMC__86_B4,3 | Lung | Primary cancer | 1,020 | Stromal | 30.5% | 0.84 | 0.37 |
| NSCLC_38242124__IMC__86_B4,5 | Lung | Primary cancer | 291 | Tumor/Malignant | 70.8% | 0.33 | 0.98 |
| NSCLC_38242124__IMC__86_B4,6 | Lung | Primary cancer | 310 | Stromal | 62.9% | 0.42 | 0.89 |
| NSCLC_38242124__IMC__86_B4,7 | Lung | Primary cancer | 1,610 | Tumor/Malignant | 68.4% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__86_B4,8 | Lung | Primary cancer | 303 | Tumor/Malignant | 54.8% | 0.45 | 0.79 |
| NSCLC_38242124__IMC__86_B4,9 | Lung | Primary cancer | 685 | Stromal | 35.3% | 0.42 | 0.89 |
| NSCLC_38242124__IMC__86_B5,1 | Lung | Primary cancer | 3,182 | Tumor/Malignant | 67.0% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__86_B5,10 | Lung | Primary cancer | 2,357 | Tumor/Malignant | 38.1% | 0.99 | 0.07 |
| NSCLC_38242124__IMC__86_B5,12 | Lung | Primary cancer | 137 | Tumor/Malignant | 51.8% | 0.46 | 0.90 |
| NSCLC_38242124__IMC__86_B5,13 | Lung | Primary cancer | 3,387 | Tumor/Malignant | 85.7% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__86_B5,14 | Lung | Primary cancer | 2,142 | Tumor/Malignant | 28.6% | 0.93 | 0.25 |
| NSCLC_38242124__IMC__86_B5,2 | Lung | Primary cancer | 2,666 | Lymphoid | 40.7% | 0.86 | 0.44 |
| NSCLC_38242124__IMC__86_B5,3 | Lung | Primary cancer | 3,885 | Lymphoid | 25.0% | 0.90 | 0.30 |
| NSCLC_38242124__IMC__86_B5,4 | Lung | Primary cancer | 2,337 | Tumor/Malignant | 29.2% | 0.91 | 0.31 |
| NSCLC_38242124__IMC__86_B5,5 | Lung | Primary cancer | 2,876 | Tumor/Malignant | 40.6% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__86_B5,6 | Lung | Primary cancer | 3,764 | Stromal | 65.0% | 0.97 | 0.09 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__86_B4,12 | Lung | Primary cancer | 3,991 | Tumor/Malignant cell | 35.8% | 0.92 | 0.38 |
| NSCLC_38242124__IMC__86_B4,13 | Lung | Primary cancer | 2,843 | Tumor/Malignant cell | 89.0% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__86_B4,14 | Lung | Primary cancer | 2,510 | Tumor/Malignant cell | 73.8% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__86_B4,2 | Lung | Primary cancer | 2,771 | Tumor/Malignant cell | 31.4% | 0.86 | 0.41 |
| NSCLC_38242124__IMC__86_B4,3 | Lung | Primary cancer | 1,020 | Fibroblast | 39.0% | 0.77 | 0.54 |
| NSCLC_38242124__IMC__86_B4,5 | Lung | Primary cancer | 291 | Tumor/Malignant cell | 70.8% | 0.33 | 1.03 |
| NSCLC_38242124__IMC__86_B4,6 | Lung | Primary cancer | 310 | Fibroblast | 62.9% | 0.33 | 1.05 |
| NSCLC_38242124__IMC__86_B4,7 | Lung | Primary cancer | 1,610 | Tumor/Malignant cell | 73.2% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__86_B4,8 | Lung | Primary cancer | 303 | Tumor/Malignant cell | 52.5% | 0.42 | 0.91 |
| NSCLC_38242124__IMC__86_B4,9 | Lung | Primary cancer | 685 | Other | 34.6% | 0.65 | 0.70 |
| NSCLC_38242124__IMC__86_B5,1 | Lung | Primary cancer | 3,182 | Tumor/Malignant cell | 67.2% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__86_B5,10 | Lung | Primary cancer | 2,357 | Tumor/Malignant cell | 52.8% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__86_B5,12 | Lung | Primary cancer | 137 | Tumor/Malignant cell | 52.6% | 0.47 | 0.90 |
| NSCLC_38242124__IMC__86_B5,13 | Lung | Primary cancer | 3,387 | Tumor/Malignant cell | 91.7% | 0.98 | 0.05 |
| NSCLC_38242124__IMC__86_B5,14 | Lung | Primary cancer | 2,142 | Tumor/Malignant cell | 32.5% | 0.90 | 0.32 |
| NSCLC_38242124__IMC__86_B5,2 | Lung | Primary cancer | 2,666 | T cell | 43.8% | 0.66 | 0.75 |
| NSCLC_38242124__IMC__86_B5,3 | Lung | Primary cancer | 3,885 | T cell | 21.6% | 0.63 | 0.88 |
| NSCLC_38242124__IMC__86_B5,4 | Lung | Primary cancer | 2,337 | Tumor/Malignant cell | 37.4% | 0.85 | 0.43 |
| NSCLC_38242124__IMC__86_B5,5 | Lung | Primary cancer | 2,876 | Tumor/Malignant cell | 50.7% | 0.95 | 0.14 |
| NSCLC_38242124__IMC__86_B5,6 | Lung | Primary cancer | 3,764 | Fibroblast | 69.6% | 0.92 | 0.18 |